146
Cardiff Oncology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
111
FY23:
77.4
FY24:
95.1
FY25:
60.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.42
FY22:
4.91
FY23:
4.23
FY24:
2.14
FY25:
1.76
Total assets
Change from FY21 to FY25
millions USD
FY21:
150
FY22:
116
FY23:
81.6
FY24:
97.2
FY25:
61.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.56
FY22:
7.81
FY23:
10.4
FY24:
13.4
FY25:
16.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.57
FY22:
2.04
FY23:
1.46
FY24:
0.81
FY25:
0.10
(positive)
Change from FY21 to FY25
millions USD
FY21:
140
FY22:
106
FY23:
69.7
FY24:
82.9
FY25:
45.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
150
FY22:
116
FY23:
81.6
FY24:
97.2
FY25:
61.9
All amounts in millions USD